News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,630 Results
Type
Article (815)
Company Profile (1)
Press Release (3814)
Section
Business (1410)
Career Advice (7)
Deals (298)
Drug Delivery (5)
Drug Development (834)
Employer Resources (6)
FDA (116)
Job Trends (110)
News (2519)
Policy (267)
Tag
Academia (40)
Allergies (1)
Alliances (289)
ALS (1)
Alzheimer's disease (30)
Antibody-drug conjugate (ADC) (7)
Approvals (118)
Artificial intelligence (8)
Autoimmune disease (1)
Automation (1)
Bankruptcy (3)
Best Places to Work (84)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (1)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (5)
Cancer (48)
Cardiovascular disease (8)
Career advice (8)
Career pathing (1)
CAR-T (3)
CDC (1)
Cell therapy (8)
Clinical research (591)
Collaboration (33)
Compensation (2)
Complete response letters (2)
COVID-19 (80)
C-suite (12)
Cystic fibrosis (1)
Data (46)
Depression (6)
Diabetes (2)
Diagnostics (28)
Digital health (1)
Drug discovery (3)
Drug pricing (3)
Drug shortages (2)
Duchenne muscular dystrophy (4)
Earnings (571)
Editorial (2)
Employer branding (2)
Employer resources (4)
Events (813)
Executive appointments (9)
FDA (141)
Friedreich's ataxia (1)
Funding (25)
Gene editing (2)
Generative AI (1)
Gene therapy (12)
GLP-1 (32)
Government (60)
Guidances (8)
Healthcare (138)
Huntington's disease (1)
Immunology and inflammation (5)
Immuno-oncology (1)
Infectious disease (80)
Inflammatory bowel disease (6)
Interviews (3)
IPO (159)
Job creations (26)
Job search strategy (2)
Labor market (1)
Layoffs (13)
Leadership (1)
Legal (51)
Liver cancer (1)
Lung cancer (11)
Lymphoma (4)
Machine learning (1)
Management (2)
Manufacturing (6)
MASH (1)
Medical device (74)
Medtech (75)
Mergers & acquisitions (138)
Metabolic disorders (26)
Neurodegenerative disease (3)
Neuropsychiatric disorders (2)
Neuroscience (44)
NextGen: Class of 2026 (59)
Non-profit (73)
Obesity (23)
Opinion (1)
Ovarian cancer (1)
Pancreatic cancer (2)
Parkinson's disease (1)
Patents (1)
Peanut (1)
People (461)
Pharmacy benefit managers (1)
Phase 1 (150)
Phase 2 (269)
Phase 3 (252)
Pipeline (40)
Policy (4)
Postmarket research (14)
Preclinical (85)
Prostate cancer (2)
Psychedelics (1)
Radiopharmaceuticals (1)
Rare diseases (12)
Real estate (31)
Recruiting (2)
Regulatory (192)
Research institute (30)
RNA editing (1)
Schizophrenia (1)
Series A (6)
Series B (5)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (1)
Startups (75)
Stomach cancer (1)
Supply chain (1)
The Weekly (1)
Vaccines (43)
Weight loss (11)
Women's health (1)
Worklife (2)
Date
Last 7 days (4)
Last 30 days (24)
Last 365 days (246)
2026 (31)
2025 (247)
2024 (349)
2023 (414)
2022 (421)
2021 (688)
2020 (442)
2019 (358)
2018 (279)
2017 (201)
2016 (141)
2015 (161)
2014 (112)
2013 (82)
2012 (86)
2011 (97)
2010 (62)
Location
Africa (3)
Arizona (1)
Asia (146)
Australia (35)
California (40)
Canada (9)
China (6)
Connecticut (4)
Delaware (1)
Europe (617)
Florida (5)
Georgia (3)
Illinois (6)
Indiana (13)
Japan (4)
Kentucky (1)
Maryland (4)
Massachusetts (71)
Minnesota (2)
Nevada (2)
New Jersey (33)
New Mexico (4)
New York (11)
North Carolina (39)
Northern California (22)
Ohio (3)
Pennsylvania (12)
South America (6)
Southern California (15)
Texas (4)
United States (283)
Utah (35)
Virginia (2)
4,630 Results for "kate therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update
January 9, 2026
·
6 min read
Press Releases
Relmada Therapeutics Appoints Distinguished Urologic Oncologist, Max Kates, MD, to the Clinical Advisory Board to Support Development of NDV-01
October 8, 2025
·
6 min read
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
Novartis’ up to $1.1 billion acquisition of gene therapy specialist Kate Therapeutics fits with the pharma’s plan to expand its new modality pipeline to ensure long-term business sustainability.
November 21, 2024
·
2 min read
·
Tristan Manalac
Business
BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
BioCorRx Inc. announced that its subsidiary BioCorRx Pharmaceuticals Inc., has appointed Kate Beebe DeVarney, Ph.D. to its Board of Directors.
February 8, 2024
·
6 min read
Business
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK) today announced the appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors, effective March 1, 2024.
March 4, 2024
·
6 min read
Business
Bicara Therapeutics Expands Board of Directors with Appointments of Kate Haviland and Scott Robertson
Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the expansion of its board of directors with the appointments of biopharmaceutical industry veterans Kate Haviland and Scott Robertson.
October 16, 2023
·
3 min read
Biotech Beach
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Astellas Pharma Inc., and Kate Therapeutics announced an exclusive license agreement to develop and commercialize KT430.
June 8, 2023
·
6 min read
Business
Rani Therapeutics Appoints Kate McKinley as Chief Business Officer
Rani Therapeutics Holdings, Inc. today announced that it has appointed Kate McKinley as its Chief Business Officer.
May 24, 2023
·
4 min read
Press Releases
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
Maravai LifeSciences, Inc. announced that Chief Innovation Officer Kate Broderick, PhD, has been named to the 2023 PharmaVoice 100 list, which recognizes the most inspiring leaders in the life sciences.
September 19, 2023
·
2 min read
Business
Capsida Biotherapeutics Enters Strategic Collaboration With Kate Therapeutics to Manufacture KateTx’s Next-Generation Gene Therapies
Capsida Biotherapeutics Inc. (“Capsida”) and Kate Therapeutics (“KateTx”) today announced a strategic partnership to leverage Capsida’s expertise and adeno-associated virus (AAV) manufacturing capabilities to enable KateTx’s initial internal portfolio of muscle and heart disease programs.
October 3, 2023
·
3 min read
1 of 463
Next
